Loading
Latest filing published 09 Jan 2023 for Wai Chun Bio-Technology Ltd.. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chen Guanyu is a declared insider of Wai Chun Bio-Technology Ltd., with filings sourced from HKEX. We count 3 filings; the first trade dates from 14 July 2020 and the latest from 12 January 2021.
Both buying and selling appear: 1 purchase worth €116k, against 2 sales worth €129k. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings no purchases and 2 sales.
On 9 January 2023 came the latest disclosure, an open-market sale in Wai Chun Bio-Technology Ltd. The last purchase on record was published on 15 July 2020, which is 2,289 days ago. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations